Since last many years Saintroy Lifescience is leading manufacture, exportand supplier of Arteether + Lumefantrine Tablets from Surat, Gujarat, India. Arteether+ Lumefantrine Tablets used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine. It is not typically used to prevent malaria.
Tags: Arteether + Lumefantrine Tablets manufacturer , Arteether + LumefantrineTablets exporter, Arteether + Lumefantrine Tablets supplier, and Arteether + Lumefantrine Tablets ,whogmp approved Arteether + LumefantrineTablets manufacturer and supplier, Arteether + Lumefantrine Tablets distributor, Arteether + Lumefantrine Tablets dropshipper, Arteether + LumefantrineTablets 20 mg/ 120 mg, Arteether + Lumefantrine Tablets 20 mg/ 120 mg supplier, Arteether + Lumefantrine Tablets 20 mg/ 120 mg.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clients country and we also provide the products samples,COA, COPP, ACTD or CTDDossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Arteether + Lumefantrine Tablets export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia,Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China,Zimbabwe,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic ofrepublic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica,Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan,Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Thank You!
Thank You for your valuable time. We have received your details and will get back to you shortly.
SAINTROY LIFESCIENCE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |